Search the Newsreel

Sprott Inc. (NYSE: SII) sets US$0.40 per share Q2 2026 dividend

Sprott Inc. has declared a second-quarter 2026 cash dividend of US$0.40 per common share. The dividend will be payable on September 1, 2026, to shareholders of record as of August 17, 2026. Canadian-registered shareholders will receive the dividend in Canadian dollars based on the …

Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update

ICOTYDE™ First Full Quarter of Commercial Sales with Strong Early Adoption Rusfertide NDA under Priority Review for Polycythemia Vera; PDUFA Date in August 2026 Comprehensive Phase 2b Program with PN-881, an Oral IL-17 Antagonist for Psoriasis, Planned to Initiate Early Q1 2027 Phase 1 …

Protagonist Therapeutics (NASDAQ: PTGX) turns Q2 2026 loss into profit

Protagonist Therapeutics (NASDAQ: PTGX) reported a significant financial turnaround in Q2 2026, shifting from a loss to a net income of $162.8 million and diluted earnings per share of $2.29. This was primarily driven by approximately $213.5 million in license and collaboration revenue, including …

Sprott (NYSE:SII) Issues Earnings Results

Proto Labs (PRLB) insider Kenison plans $947K stock sale in Form 144

Proto Labs (PRLB) shareholder Michael R. Kenison has filed a Form 144, indicating a planned sale of 10,753 shares of common stock valued at approximately $947,786.62 through Morgan Stanley Smith Barney LLC on the NYSE. The filing also details Kenison's prior acquisitions through restricted …

Earnings call transcript: Sprott beats Q2 2026 EPS, shares jump 10%

Sprott Inc. reported strong Q2 2026 earnings per share of $1.33, surpassing Wall Street estimates, despite revenue missing forecasts. The company saw net income and adjusted EBITDA rise significantly due to strong operating leverage and higher average assets under management, though ending AUM declined. …

Sprott (NYSE:SII) Trading Up 10.3% Following Dividend Announcement

Sprott (NYSE:SII) shares rose 10.3% after announcing a quarterly dividend of $0.40 per share. The company reported EPS of $1.33, slightly missing consensus estimates but significantly higher than the previous year. Analysts maintain a "Moderate Buy" rating with a $230 price target, and institutional …

Sprott Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Sprott Inc. TORONTO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) ("Sprott" or the "Company") today announced its financial results for the three and six months ended June 30, 2026. Management commentary "Sprott's Assets Under Management ("AUM") were $55.6 billion as at …

Sprott Inc. (NYSE:SII) Announces $0.40 Quarterly Dividend

Sprott Inc. (NYSE:SII) has declared a quarterly dividend of $0.40 per share, payable on September 1st to shareholders of record on August 17th. This dividend represents an annualized yield of 1.5% and a payout ratio of 67.8%. The company recently exceeded analyst expectations in …

Stocks in play: Sprott Inc.

Sprott Inc. announced its financial results for Q2 2026, reporting Assets Under Management (AUM) of $55.6 billion as of June 30, 2026. This figure represents a 15% decrease from the previous quarter and a 7% decrease from the end of 2025. Following the announcement, …

Earnings Flash (SII) Sprott Inc. Reports Q2 Revenue $80.2M, vs. FactSet Est of $82.5M

Sprott Inc. (SII) reported its Q2 revenue at $80.2 million, falling short of the FactSet estimate of $82.5 million. The company, a Canada-based global asset manager specializing in precious metals and critical materials, also recently declared a dividend for Q2 2026. Analysts maintain a …

Sprott Announces Second Quarter 2026 Results

Sprott Inc. TORONTO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) ("Sprott" or the "Company") today announced its financial results for the three and six months ended June 30, 2026. Management commentary "Sprott's Assets Under Management ("AUM") were $55.6 billion as at …

Royal Bank of Canada Acquires 45,120 Shares of Sprott Inc. $SII

Protean eGov Technologies Q1 results FY27: PAT Rs 5 Cr, Revenue R

Sprott (SII) Earnings Date and Reports 2026 $SII

Protean eGov shares fall 6% despite 19% YoY jump in Q1 revenue. Should you buy, sell or hold?

Protagonist Therapeutics (PTGX) Earnings Date and Reports 2026

Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Protagonist Therapeutics (PTGX) came out with quarterly earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.11 per share. This compares to a loss of $0.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

Sprott Inc. 2026 Q2 - Results - Earnings Call Presentation (TSX:SII:CA) 2026-08-05

Protean eGov shares tumble 8% as Q1 profit slumps 75%, margins hit two-year low

Prothena Corporation PLC expected to post a loss of 39 cents a share - Earnings Preview

Prothena Corporation PLC is projected to report a loss of 39 cents per share in its upcoming earnings. This information is provided as an earnings preview by Refinitiv. The full article is available through a TradingView subscription.

Intelligent Protection Invites Questions Before Aug. 11 Call

Proto Labs (NYSE:PRLB) Hits New 12-Month High After Analyst Upgrade

Proto Labs (NYSE:PRLB) reached a new 52-week high after Needham & Company LLC upgraded the stock from a "hold" to a "buy" rating with an $87 price target. The company reported strong Q2 earnings, beating analyst estimates, and provided positive Q3 guidance. Despite institutional …

PTGX|Protagonist Therapeutics Inc|Price:132.170|Chg%:-4.470

This article provides an in-depth analysis of Protagonist Therapeutics Inc. (PTGX), covering its market trends, real-time quotes, and related analysis. It highlights the company's strong fundamentals and growth potential, despite a recent turnaround to loss, and offers a comprehensive look at its financial indicators, …

Two New Hires Get Protagonist Stock Awards Vested Over Four Years

Protagonist Therapeutics granted inducement equity awards to two new employees on July 31, 2026, comprising options to purchase 7,300 shares and 1,975 Restricted Stock Units (RSUs). These awards, with an exercise price matching the July 31 Nasdaq closing price of $136.64, are designed to …

19,015 Shares in Proto Labs, Inc. $PRLB Acquired by Edgestream Partners L.P.

Edgestream Partners L.P. acquired a new stake of 19,015 shares in Proto Labs, Inc. (NYSE:PRLB) during the first quarter, valued at approximately $1.08 million. Institutional investors collectively own 84.54% of the company's stock, despite some insider selling totaling $1.80 million during the last quarter. …

Sprott faces earnings test as precious metals volatility bites

Sprott Inc. is set to release its second-quarter results, with analysts expecting significant year-over-year growth in earnings and revenue despite recent volatility in precious metals prices. Investors will be closely watching for sustained assets under management growth, the performance of new exchange-traded products, and …

Protean eGov Technologies Q1 Results: Earnings call audio uploaded

Sprott declares $0.40 dividend

* Sprott (SII [https://seekingalpha.com/symbol/SII]) declares $0.40/share quarterly dividend [https://seekingalpha.com/pr/20606397-sprott-inc-declares-second-quarter-2026-dividend], in line with previous. * Forward yield [https://seekingalpha.com/symbol/SII/dividends/yield?source=news_bullet] 1.53% * Payable Sept. 1; for shareholders of record Aug. 17; ex-div Aug. 17. * See SII Dividend Scorecard, Yield Chart, & Dividend Growth. [https://seekingalpha.com/symbol/SII/dividends?source=news_bullet]

Sprott Inc. Declares Second Quarter 2026 Dividend

Sprott Inc. TORONTO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sprott Inc. ("Sprott" or the "Company") (NYSE/TSX: SII) announced today that its Board of Directors has declared a second quarter 2026 dividend of US$0.40 per common share, payable on September 1, 2026 to shareholders of …

Proto Labs stock hits 52-week high at 83.19 USD By Investing.com

Proto Labs Inc (PRLB) has hit a new 52-week high of $83.19, reflecting an 85% stock price increase over the past year and significant year-to-date and six-month gains. This surge follows strong Q2 results, exceeding Wall Street expectations with record revenue and adjusted earnings, …

Proto Labs Aktie erreicht 52-Wochen-Hoch bei 83,19 USD

Proto Labs (PRLB) Gets a Buy from Cantor Fitzgerald

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Pioneer with Robust Revenue Growth and Promising Pipeline

What Proto Labs (PRLB) Guidance Raise Means For Its Valuation

Proto Labs, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:PRLB) 2026-08-04

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Suresh KrishnaChief Financial Officer - Dan SchumacherInvestor Relations - Ryan Johnsrud TAKEAWAYS Revenue -- $149.3 million, up 10.2% in constant currency, representing …